| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
TriSalus Life Sciences, Inc.
13D/A
Amendment 3
TLSI · 89680M101
|
14.0% |
8/4/2025
Event 7/31/2025
|
|||
| Frankenius Equity AB | 14.0% | ||||
| Paul Frankenius | 14.0% | ||||
|
TriSalus Life Sciences, Inc.
13D/A
Amendment 2
TLSI · 89680M101
|
20.5% |
5/2/2025
Event 4/30/2025
|
|||
| Frankenius Equity AB | 20.5% | ||||
| Paul Frankenius | 20.5% | ||||
|
TriSalus Life Sciences, Inc.
13D/A
Amendment 1
TLSI · 89680M101
|
20.9% |
12/19/2024
Event 12/17/2024
|
|||
| Frankenius Equity AB | 20.9% | ||||
| Paul Frankenius | 20.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.